Hans-Peter Rudolf

Global Chief Financial Officer

Prior to joining ReLive Biotechnologies, Hans-Peter was the Chief Financial Officer at Shield Therapeutics, a UK-listed commercial-stage pharmaceutical company, where he brought extensive international experience to the senior leadership team. Hans-Peter initially began his career in 1991 as a financial auditor with Deloitte in Cleveland, Ohio. He then joined Ernst & Young (EY) in Zurich, Switzerland, and subsequently moved back to Cleveland to first work in EY’s Global Assurance Group and later as an audit partner at Crowe Horwath (now Crowe), the eighth largest global accounting network. After 20 years as a financial auditor, Hans-Peter left public practice in 2011 to become Head of Group Accounting at COFRA Group, a privately held Swiss family-owned conglomerate with activities in retail, commercial real estate, and private equity, employing over 50,000 people worldwide. In 2017, he was appointed Chief Financial Officer at Vicarius Pharma, a start-up company offering research-driven pharma and biotech companies a platform to build a dedicated European commercial organization to market and sell their assets through long-term license and partnership agreements.

Hans-Peter studied at the University of Zurich and Cleveland State University, Ohio, and is a US Certified Public Accountant (CPA).